NORTHWEST BIOTHERAPEUTICS INC Quarterly Operating Margin in % from Q4 2018 to Q1 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Northwest Biotherapeutics Inc quarterly/annual Operating Margin history and growth rate from Q4 2018 to Q1 2024.
  • Northwest Biotherapeutics Inc Operating Margin for the quarter ending March 31, 2024 was -4.36K %, a 38.9% decline year-over-year.
  • Northwest Biotherapeutics Inc annual Operating Margin for 2023 was -2.87K %, a 28% increase from 2022.
  • Northwest Biotherapeutics Inc annual Operating Margin for 2022 was -3.99K %, a 23.9% increase from 2021.
  • Northwest Biotherapeutics Inc annual Operating Margin for 2021 was -5.24K %, a 21.8% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -4.36K -1.22K -38.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -2.87K +1.12K +28% Oct 1, 2023 Dec 31, 2023
Q3 2023 -2.81K +2.69K +48.9% Jul 1, 2023 Sep 30, 2023
Q2 2023 -3.2K +1.2K +27.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -3.14K +744 +19.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 -3.99K +1.25K +23.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -5.5K -1.16K -26.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -4.4K +3.11K +41.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -3.89K +6.36K +62.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -5.24K +1.46K +21.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 -4.34K -168 -4.02% Jul 1, 2021 Sep 30, 2021
Q2 2021 -7.51K -6.11K -435% Apr 1, 2021 Jun 30, 2021
Q1 2021 -10.2K -9.18K -865% Jan 1, 2021 Mar 31, 2021
Q4 2020 -6.71K -5.55K -478% Oct 1, 2020 Dec 31, 2020
Q3 2020 -4.17K -1.91K -84.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 -1.4K +1.49K +51.6% Apr 1, 2020 Jun 30, 2020
Q1 2020 -1.06K +5.47K +83.7% Jan 1, 2020 Mar 31, 2020
Q4 2019 -1.16K +8.91K +88.5% Oct 1, 2019 Dec 31, 2019
Q3 2019 -2.26K Jul 1, 2019 Sep 30, 2019
Q2 2019 -2.9K Apr 1, 2019 Jun 30, 2019
Q1 2019 -6.53K Jan 1, 2019 Mar 31, 2019
Q4 2018 -10.1K Oct 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.